Jen MH - Search Results

1

Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.

Longo F, Jorge M, Yaya R, Montes AF, Lago NM, Brozos E, Aparicio J, Quintero G, Ceballos E, Buxó E, Lopez AM, Pellón ML, Molina R, Diaz-Paniagua L, Cerdà P, Leiva PL, Carnicero AM, Cousillas A, Paris L, García-Paredes B, Romero C, Ortega M, Molero A, la Torre S, Jen MH, Díaz-Cerezo S. Longo F, et al. Among authors: jen mh. Future Oncol. 2021 May;17(14):1777-1791. doi: 10.2217/fon-2020-1216. Epub 2021 Feb 16. Future Oncol. 2021. PMID: 33590772 Free article.

2

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.

Yamaguchi K, Shimada Y, Hironaka S, Sugimoto N, Komatsu Y, Nishina T, Omuro Y, Tamura T, Piao Y, Homma G, Jen MH, Liepa AM, Muro K. Yamaguchi K, et al. Among authors: jen mh. Clin Drug Investig. 2021 Jan;41(1):53-64. doi: 10.1007/s40261-020-00979-3. Epub 2020 Dec 23. Clin Drug Investig. 2021. PMID: 33355909 Free PMC article. Clinical Trial.

3

Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.

Kudo M, Galle PR, Llovet JM, Finn RS, Vogel A, Motomura K, Assenat E, Merle P, Brandi G, Daniele B, Okusaka T, Tomášek J, Borg C, Dadduzio V, Morimoto M, Pracht M, Jen MH, Drove Ubreva N, Widau RC, Shinozaki K, Yoshikawa R, Zhu AX. Kudo M, et al. Among authors: jen mh. Liver Int. 2020 Aug;40(8):2008-2020. doi: 10.1111/liv.14462. Epub 2020 May 6. Liver Int. 2020. PMID: 32279446 Free article. Clinical Trial.

4

Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.

Hofheinz R, Clouth J, Borchardt-Wagner J, Wagner U, Weidling E, Jen MH, Brück P. Hofheinz R, et al. Among authors: jen mh. BMC Cancer. 2016 Dec 6;16(1):937. doi: 10.1186/s12885-016-2975-9. BMC Cancer. 2016. PMID: 27923357 Free PMC article.

5

Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data.

Muro K, Jen MH, Cheng R. Muro K, et al. Among authors: jen mh. Cancer Manag Res. 2019 Mar 20;11:2261-2267. doi: 10.2147/CMAR.S193739. eCollection 2019. Cancer Manag Res. 2019. PMID: 30962715 Free PMC article.

6

KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.

Goulding RE, Chenoweth M, Carter GC, Boye ME, Sheffield KM, John WJ, Leusch MS, Muehlenbein CE, Li L, Jen MH, Rojubally A, Jansen J, Druyts E. Goulding RE, et al. Among authors: jen mh. Cancer Treat Res Commun. 2020;24:100200. doi: 10.1016/j.ctarc.2020.100200. Epub 2020 Jul 25. Cancer Treat Res Commun. 2020. PMID: 32750661 Free article.

7

Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.

Wirth LJ, Robinson B, Boni V, Tan DSW, McCoach C, Massarelli E, Hess LM, Jen MH, Kherani J, Olek E, Subbiah V. Wirth LJ, et al. Among authors: jen mh. Oncologist. 2022 Feb 3;27(1):13-21. doi: 10.1002/onco.13977. Oncologist. 2022. PMID: 34516023 Free PMC article. Clinical Trial.

8

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.

Vickers AD, Winfree KB, Cuyun Carter G, Kiiskinen U, Jen MH, Stull D, Kaye JA, Carbone DP. Vickers AD, et al. Among authors: jen mh. BMC Cancer. 2019 Apr 15;19(1):353. doi: 10.1186/s12885-019-5569-5. BMC Cancer. 2019. PMID: 30987609 Free PMC article.

9

Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis.

Parikh AR, Gonzalez-Gugel E, Smolyakova N, Jen MH, Toms N, Lin Y, Kim JS, Kopetz S. Parikh AR, et al. Among authors: jen mh. Oncologist. 2022 May 6;27(5):371-379. doi: 10.1093/oncolo/oyab030. Oncologist. 2022. PMID: 35522557 Free PMC article. Review.

10

Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial.

Minchom A, Tan AC, Massarelli E, Subbiah V, Boni V, Robinson B, Wirth LJ, Hess LM, Jen MH, Kherani J, Olek E, McCoach CE. Minchom A, et al. Among authors: jen mh. Oncologist. 2022 Feb 3;27(1):22-29. doi: 10.1002/onco.13976. Oncologist. 2022. PMID: 34523767 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page